Roth Capital Upgrades Cogentix Medical (CGNT) to Buy

November 5, 2015 7:24 AM

Roth Capital upgraded Cogentix Medical (NASDAQ: CGNT) from Neutral to Buy with a price target of $3.00 (from $1.85).Analyst Chris ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found